Conventional RT–PCR studies using isolated and disaggregated crypt epithelial cells from normal control and IBD mucosal samples showed amplification products specific for TLR-2 and TLR-4 (see Supporting information, Figure S1). This evidence concerns the gene TLR4 and inflammatory bowel disease.